1. 2023 ESC Guidelines for the management of cardiomyopathies;Arbelo;Eur Heart J,2023
2. 2020 AHA/ACC Guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: Executive Summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Ommen;Circulation,2020
3. Mansencal N, Charron P, Dubourg O. Protocole national de diagnostic et de soins (PNDS) sur la cardiomyopathie hypertrophique (septembre 2021). https://www.has-sante.fr/jcms/c_1100272/fr/cardiomyopathie-hypertrophique.
4. Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association;Cardim;Eur Heart J Cardiovasc Imaging,2015
5. Role of multimodality imaging in the diagnosis and management of cardiomyopathies;Ederhy;Arch Cardiovasc Dis,2019